COPD Symposia
In this section
GOLD 2023 – Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD
This symposium explores the heterogeneous clinical presentation of chronic obstructive pulmonary disease (COPD), addressing variations in severity, symptoms, and comorbidities.
Learning objectives
- Understand the heterogeneous clinical presentation of COPD (eg, severity, level of control, symptoms, multimorbidities)
- Review the role of underlying inflammation in COPD pathology and its link to clinical features
- Review the role of biomarker assessments and endotyping in COPD
Meet the expert
Igor Barjaktarevic, MD, PhD
Assistant Professor of Medicine, Medical Director of COPD Program – David Geffen School of Medicine at University of California-Los Angeles (UCLA)
As Assistant Professor of Medicine and Medical Director of the COPD Program at the David Geffen School of Medicine at UCLA, Dr. Barjaktarevic leads the clinical and research projects in COPD and alpha-1 antitrypsin deficiency syndrome.
With a fairly extensive background in the field of pulmonary immunology where Dr. Barjaktarevic obtained a PhD in 2016 in collaborative project between University of Belgrade and Weill Cornell in New York, his research experience expands from basic science and experiments on laboratory animals to complete conduction of clinical or translational studies.
Disclosures:
Dr. Barjaktarevic has received funding from Alpha-1 Foundation, COPD Foundation, Johnny Carson Foundation, and NIH National Heart, Lung, and Blood Institute; grants from Aerogen, GE HealthCare, Takeda, Theravance, and Viatris; and has consulting relationships with AstraZeneca, Grifols, Inhibrx, Regeneron, Sanofi, Takeda, and Verona Pharma.
of interest
are looking at
saved
next event
Developed by EPG Health for Medthority in collaboration with Sanofi and Regeneron, with content provided by Sanofi and Regeneron. ADVENT is a medical education non-promotional program for healthcare professionals organized by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals.
© 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
MAT-US-2405120 V1.0 – P Exp Date: 06/11/2026.
Sanofi and Regeneron are committed to providing resources to advance knowledge in areas of unmet medical need among patients with inflammatory and immunologic diseases.